| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Smith Mervin | EVP Strategic Business Ops | C/O IRHYTHM HOLDINGS, INC., 699 8TH STREET, #600, SAN FRANCISCO | /s/ Marc Rosenbaum, attorney-in-fact | 26 Feb 2026 | 0001985217 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IRTC | Common Stock | Award | $0 | +9,210 | +61% | $0.000000 | 24,316 | 24 Feb 2026 | Direct | F1 |
| transaction | IRTC | Common Stock | Sale | $547,228 | -4,041 | -17% | $135.42 | 20,275 | 25 Feb 2026 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 11, 2023. |
| F2 | These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs. |